Baird Medical Seeks 1-for-50 Reverse Split and Dual-Class Control for CEO Wu
BDMD sits 27% above its 52-week low of $0.073.
Summary
At its November 30, 2026 shareholder vote, Baird Medical seeks a 1-for-50 reverse split to cure its Nasdaq bid-price deficiency, a dual-class structure giving CEO Haimei Wu 100-vote shares, and a nominal-price repurchase of 18.2M shares from AUTO KING.
Key Events · Corporate Governance and Compliance · BDMD
-
1-for-50 Reverse Split Proposed
Every 50 ordinary shares would consolidate into one at US$0.005 par, effective on a date confirmed by Nasdaq, to regain the $1.00 minimum bid price.
-
Dual-Class Structure Empowers CEO
Authorized capital splits into 480,000,000 Class A (1 vote) and 20,000,000 Class B (100 votes); all 56,518,768 issued shares become Class A, with Haimei Wu the sole Class B holder.
-
Related-Party Share Repurchase
The company would buy back 18,195,281 Class A shares from AUTO KING INTERNATIONAL LIMITED for US$1,819.53 nominal, funded by a fresh issue of 18,195,281 Class B shares, leaving issued capital unchanged.
-
Nasdaq Deadline May 3, 2027
A deficiency notice received November 5, 2026 gives 180 days to comply; the filing warns delisting could impair the ability to raise equity or debt.
Analysis · BDMD · Industrial Applications And Services
Delisting risk is the driver: Baird Medical wants shareholder approval for a 1-for-50 reverse split to lift its $0.0924 share price back above Nasdaq's $1.00 minimum before the May 3, 2027 deadline, warning that failure would impair its ability to raise financing. The same ballot hands founder/CEO Haimei Wu a Class B block with 100 votes per share, entrenching her majority control and potentially letting the company use Nasdaq 'controlled company' exemptions from independent-board rules. A related-party restructuring—not a capital raise—sits alongside: the repurchase of 18,195,281 shares from AUTO KING for a nominal US$1,819.53, funded by issuing Class B shares, shifts ownership. Approval is likely given Wu's stake, since all proposals need only a majority (two-thirds for the charter amendment) of votes cast at the November 30, 2026 meeting.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BDMD was trading at $0.09 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.07 to $3.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.